The difference between IPIX and other small biotec
Post# of 72446
(Total Views: 247)
Posted On: 08/25/2017 9:02:18 AM
The difference between IPIX and other small biotechs is that:
• we have the goods (great science that's been successful in clinical trials);
• we don't have bad financing (and we don't have crushing debt);
• we have a management that is hugely invested in the company and willing to fight back against those who attack the company.
It's nothing short of astonishing to see that we have 3 totally different drugs that have thus far been successful in clinical trials for 5 different applications. There are many small biotechs that have NO drugs that have reached clinical trial stage for even a single drug --
yet they have a higher market cap.
Why is that? It sure isn't for any of the BS that the bashers spew at other sites (and which I won't repeat). It's because a concerted attack was mounted on this company by a well-funded group which was successful in taking the share price down through manipulation and articles and tweets which scared people away from even investigating the company.
Now, we have a dedicated and knowledgeable shareholder base that WILL NOT be scared away by whatever tactics they try. From communications with others, it is clear that
IF THEY TRY TO TAKE THE PRICE DOWN, WE WILL BUY.
I do not think that there are very many real shares available to trade now, and some of us including me have been buying this week near the lows.
I think 4kids is absolutely right that the manipulators are in deep trouble.
And the very low volume we've been having for well over a week is a huge change in trading style too.
We will be having some kind of news soon, and if it is great, we should go up nicely. I think we should be trading at a minimum of 4 with the progress we've made so far, so perhaps news will take us back there.
And if somehow they manage to keep the share price down, well, I'll just keep buying. And so will others.
• we have the goods (great science that's been successful in clinical trials);
• we don't have bad financing (and we don't have crushing debt);
• we have a management that is hugely invested in the company and willing to fight back against those who attack the company.
It's nothing short of astonishing to see that we have 3 totally different drugs that have thus far been successful in clinical trials for 5 different applications. There are many small biotechs that have NO drugs that have reached clinical trial stage for even a single drug --
yet they have a higher market cap.
Why is that? It sure isn't for any of the BS that the bashers spew at other sites (and which I won't repeat). It's because a concerted attack was mounted on this company by a well-funded group which was successful in taking the share price down through manipulation and articles and tweets which scared people away from even investigating the company.
Now, we have a dedicated and knowledgeable shareholder base that WILL NOT be scared away by whatever tactics they try. From communications with others, it is clear that
IF THEY TRY TO TAKE THE PRICE DOWN, WE WILL BUY.
I do not think that there are very many real shares available to trade now, and some of us including me have been buying this week near the lows.
I think 4kids is absolutely right that the manipulators are in deep trouble.
And the very low volume we've been having for well over a week is a huge change in trading style too.
We will be having some kind of news soon, and if it is great, we should go up nicely. I think we should be trading at a minimum of 4 with the progress we've made so far, so perhaps news will take us back there.
And if somehow they manage to keep the share price down, well, I'll just keep buying. And so will others.
(3)
(0)